Literature DB >> 12227729

Cardiovascular changes in chronic renal failure--pathogenesis and therapy.

K Amann1, K Tyralla.   

Abstract

Cardial death caused by ischemia, which is not necessarily connected with coronary arterial changes, represents the main death cause in chronic renal failure patients. The present overview article compiles the latest findings on structural and functional changes of the heart and vessels in uremia, which have a potential effect on the ischemia tolerance of the myocardium and thus help to explain the high cardiovascular mortality in chronic renal failure. The cardiovascular structural changes comprise: 1. A left ventricular myocardium hypertrophy, 2. an interstitial myocardium fibrosis and 3. changes in the myocardial microcirculation like, above all, a rarefaction of the intramyocardial capillaries with increase in the intercapillary oxygen diffusion passage and a vascular wall thickening of intramyocardial arteries. In addition, characteristic metabolic changes, like for instance a decrease of phosphates rich in energy, which contribute likewise to a heightened ischemia sensitivity of the myocardium. At the same time an involvement of extra-myocardial vascular changes is also probable in the development of the prognostically unfavorable myocardium hypertrophy in chronic renal failure. These extracardial vascular changes consist, above all, of a wall thickening of the aorta, of the peripheral arteries and veins with reduction of the share of elastic fiber, of an increase in the extracellular matrix and of a diffuse media calcification and lead to an increase in vascular stiffness and to reduction of aortal compliance.

Entities:  

Mesh:

Year:  2002        PMID: 12227729

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

1.  Nonparallel Progression of Left Ventricular Structure and Function in Long-Term Peritoneal Dialysis Patients.

Authors:  Qiuhong Shi; Jing Zhu; Sheng Feng; Huaying Shen; Jianchang Chen; Kai Song
Journal:  Cardiorenal Med       Date:  2017-04-22       Impact factor: 2.041

2.  Relationship between renal function at the time of percutaneous coronary intervention and prognosis in ischemic heart disease patients.

Authors:  Daijo Inaguma; Miho Tatematsu; Hibiki Shinjo; Sachiyo Suzuki; Tomoko Mishima; Shinichiro Inaba; Kei Kurata; Yukio Yuzawa; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2007-03-28       Impact factor: 2.801

3.  Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.

Authors:  Maartje C J Slagman; Tri Q Nguyen; Femke Waanders; Liffert Vogt; Marc H Hemmelder; Gozewijn D Laverman; Roel Goldschmeding; Gerjan Navis
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

4.  Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease.

Authors:  Y Bai; W Sigala; G R Adams; N D Vaziri
Journal:  Am J Nephrol       Date:  2008-09-17       Impact factor: 3.754

5.  Simultaneous cardiac and renal damage in a hypertensive population.

Authors:  Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-06       Impact factor: 3.738

Review 6.  The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Marco Pellegrini; Carmelo De Gori; Gabriele Del Castillo; Nicola Giordano; Ranuccio Nuti
Journal:  Ther Clin Risk Manag       Date:  2014-08-13       Impact factor: 2.423

7.  Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction.

Authors:  Antoinette Bugyei-Twum; Armin Abadeh; Kerri Thai; Yanling Zhang; Melissa Mitchell; Golam Kabir; Kim A Connelly
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

Review 8.  Mechanisms of cardiac fibrosis in hypertension.

Authors:  Javier Díez
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-07       Impact factor: 3.738

9.  The relationship between mean arterial pressure and decreased glomerular filtration rate in rural areas of Northeast China.

Authors:  Hongmei Yang; Xiaofan Guo; Xingang Zhang; Zhao Li; Shasha Yu; Liqiang Zheng; Wenna Li; Ying Zhou; Yingxian Sun
Journal:  BMC Nephrol       Date:  2015-08-13       Impact factor: 2.388

10.  Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.

Authors:  Nicole Arend; Karl F Hilgers; Valentina Campean; Britta Karpe; Nada Cordasic; Bernd Klanke; Kerstin Amann
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.